Trophoblast cell surface antigen 2 (Trop2), a type I cell surface glycoprotein, shows limited expression in normal tissues but over-expression in various types of tumors, including breast cancer, NSCLC, pancreatic cancer, and other tumors. This evidence concerns the gene TACSTD2 and breast carcinoma.